Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure

BACKGROUND: Approximately 2–3% of patients undergoing advanced heart failure therapies such as left ventricular assist devices (LVAD) and orthotropic heart transplantation (OHT) have chemotherapy-related cardiomyopathy, according to analyses of large databases such as United Network for Organ Sharin...

Descripción completa

Detalles Bibliográficos
Autores principales: Araujo-Gutierrez, Raquel, Ibarra-Cortez, Sergio H., Estep, Jerry D., Bhimaraj, Arvind, Guha, Ashrith, Hussain, Imad, Park, Myung H., Torre-Amione, Guillermo, Trachtenberg, Barry H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048122/
https://www.ncbi.nlm.nih.gov/pubmed/32154004
http://dx.doi.org/10.1186/s40959-018-0029-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048122/
https://www.ncbi.nlm.nih.gov/pubmed/32154004
http://dx.doi.org/10.1186/s40959-018-0029-y

Ejemplares similares